BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24691581)

  • 1. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
    Magdalinou N; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1065-75. PubMed ID: 24691581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
    Magdalinou NK; Noyce AJ; Pinto R; Lindstrom E; Holmén-Larsson J; Holtta M; Blennow K; Morris HR; Skillbäck T; Warner TT; Lees AJ; Pike I; Ward M; Zetterberg H; Gobom J
    Parkinsonism Relat Disord; 2017 Apr; 37():65-71. PubMed ID: 28214264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism.
    Constantinescu R; Rosengren L; Eriksson B; Blennow K; Axelsson M
    Acta Neurol Scand; 2019 Aug; 140(2):147-156. PubMed ID: 31070772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F; Ding J; Liu Y; Lin H; Chang T
    Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flt3 ligand does not differentiate between Parkinsonian disorders.
    Silajdžić E; Constantinescu R; Holmberg B; Björkqvist M; Hansson O
    Mov Disord; 2014 Sep; 29(10):1319-22. PubMed ID: 25044107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders.
    Constantinescu R; Andreasson U; Li S; Podust VN; Mattsson N; Anckarsäter R; Anckarsäter H; Rosengren L; Holmberg B; Blennow K; Wikkelsö C; Rüetschi U; Zetterberg H
    Parkinsonism Relat Disord; 2010 Sep; 16(8):545-9. PubMed ID: 20620095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling in Parkinsonian syndromes: CSF biomarkers.
    Paolini Paoletti F; Gaetani L; Parnetti L
    Clin Chim Acta; 2020 Jul; 506():55-66. PubMed ID: 32142717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
    Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
    Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
    Litvan I; Bhatia KP; Burn DJ; Goetz CG; Lang AE; McKeith I; Quinn N; Sethi KD; Shults C; Wenning GK;
    Mov Disord; 2003 May; 18(5):467-86. PubMed ID: 12722160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives.
    Oeckl P; Steinacker P; Feneberg E; Otto M
    Biochim Biophys Acta; 2015 Jul; 1854(7):757-68. PubMed ID: 25526887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease.
    von Euler Chelpin M; Söderberg L; Fälting J; Möller C; Giorgetti M; Constantinescu R; Blennow K; Zetterberg H; Höglund K
    J Parkinsons Dis; 2020; 10(4):1429-1442. PubMed ID: 33016895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarker candidates for parkinsonian disorders.
    Constantinescu R; Mondello S
    Front Neurol; 2012; 3():187. PubMed ID: 23346074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.